Share

Are Essential Oils Endocrine Disruptors?

An ENDO 2018 presentation that linked essential oils to gynecomastia in prepubertal boys caused a bit of an uproar in the spring. The study authors detail what their research means, why certain populations should be mindful of essential oil use, and the importance of future studies. A study presented this past March at ENDO 2018...
Share

Whisk’s AI-Powered Culinary Coach Named as Winner of Ascensia Diabetes Challenge

During the American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care revealed that UK-based Whisk was selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that set out to find digital solutions to support type 2 diabetes management. Whisk’s winning innovation is a Culinary Coach that uses artificial...
Share

South Asian Immigrants Exposed to Pesticides Have Increased Risk of Diabetes

South Asian immigrants exposed to higher levels of organochlorine (OC) pesticides also are at a higher risk of developing diabetes, meaning there could be a positive association between these pesticides and incidence of diabetes, according to a study recently published in the Journal of the Endocrine Society. Researchers led by Martyn T. Smith, PhD, of...
Share

Major Academic Health System Taps Glytec for Insulin Management Technology

Duke University Health System has selected Glytec’s eGlycemic Management System® to elevate the quality and safety of care for patients with diabetes and others who require insulin therapy. With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance...
Share

More from ADA 2018: Dapagliflozin in Combination with Saxagliptin Demonstrates Similar Glycemic Control with Additional Benefits vs. Insulin Glargine in Patients with Type 2 Diabetes

Data on the use of dapagliflozin in diverse patient populations with type 2 and type 1 diabetes (T2D, T1D) at the American Diabetes Association (ADA) 78th Scientific Sessions in Orlando, Fla. reinforce the use of dapagliflozin as a treatment option to help improve glycemic control when used with the DPP-4 inhibitor saxagliptin versus older treatment...
Share

News from ADA 2018

Real-World Study of More than 700,000 People with Type 2 Diabetes (T2D) Shows No Increased Risk of Below-Knee Lower Extremity Amputations with Canagliflozin Compared to Other Diabetes Medications A new real-world analysis of more than 700,000 U.S. T2D patients found no increased risk of below-knee lower extremity (BKLE) amputation with canagliflozin compared to other sodium glucose...

As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.

This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.